Received Aug 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
fever; severe chills; This non-serious case was reported by a consumer via sales rep and described the occurrence of fever in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced fever (Verbatim: fever) and chills (Verbatim: severe chills). The patient was treated with ibuprofen (Advil) and paracetamol (Tylenol). The outcome of the fever was resolved and the outcome of the chills was not reported. It was unknown if the reporter considered the fever and chills to be related to Shingrix. It was unknown if the company considered the fever and chills to be related to Shingrix. Additional Information: GSK Receipt Date: 28-JUL-2025 Shingrix first dose had caused a fever on the night of the first dose. The day after receiving the first dose, she had developed a 105-degree fever accompanied by severe chills. She had taken Advil and Tylenol to help manage the fever. The fever had lasted overnight, and she had recovered by the third day with no remaining symptoms. This had occurred following dose 1. She had not yet received dose 2.
Test Name: Body temperature; Result Unstructured Data: (Test Result:105,Unit:degree C,Normal Low:,Normal High:)